Shen Wang is a postdoctoral scholar investigating the pancreatic m6A epitranscriptomic landscape at single-cell resolution in diabetes and aging. He earned his PhD from China Pharmaceutical University, where he specialized in m6A RNA modification in stem cell biology. His current research aims to elucidate disease-associated m6A regulatory mechanisms that drive pancreatic dysfunction and metabolic disorders, with the long-term goal of identifying novel therapeutic targets for diabetes and age-related diseases.